Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Create Alert
Watchlist
Caplin Point Laboratories
₹2,019.40
+49.90 (2.53%) 1D
Create Stock SIPAutomate your investments in this
Performance
Open
1,970.20Prev. Close
1,969.50Volume
51,147Total traded value
10.33 CrUpper Circuit
2,363.40Lower Circuit
1,575.60Fundamentals
| Market Cap | ₹14,967Cr |
| ROE | 18.81% |
| P/E Ratio(TTM) | 26.40 |
| EPS(TTM) | 74.58 |
| P/B Ratio | 5.25 |
| Dividend Yield | 0.28% |
| Industry P/E | 34.98 |
| Book Value | 375.01 |
| Debt to Equity | 0.00 |
| Face Value | 2 |
Understand Fundamentals
Financials
About Caplin Point Labs
Caplin Point is a fast-growing pharmaceutical company from India, developing and marketing a wide range of generic and branded medicines globally. Its core business model involves serving less competitive, unconventional markets and managing its entire supply chain from production to last-mile distribution. This strategy has enabled the company to establish over 30,000 distribution touch points in the Latin American market alone.;
| Parent Organisation | Caplin Point Laboratories Limited |
| Managing Director | Dr. Sridhar Ganesan |
| NSE Symbol | CAPLIPOINT |
Shareholding Pattern
Jun '24
Sep '24
Dec '24
Mar '25
Jun '25
Top Mutual Funds Invested(4)
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Torrent Pharmaceuticals | NA (0.00%) | 59.49 | ||
| Gland Pharma | NA (0.00%) | 41.04 | ||
| Ajanta Pharma | NA (0.00%) | 32.14 | ||
| Eris Lifesciences | NA (0.00%) | 53.02 |